Benjamin Musher1, Ahmad Rahal1. Show Affiliations » 1. Baylor College of Medicine, Houston, Texas (B.M., A.R.).
Abstract
Entities: Disease Species
Mesh： See more » Adenocarcinoma/drug therapyAdenocarcinoma/geneticsAntibodies, Monoclonal, Humanized/therapeutic useAntineoplastic Agents, Immunological/therapeutic useCholangiocarcinoma/drug therapyCholangiocarcinoma/geneticsColonic Neoplasms/drug therapyColonic Neoplasms/geneticsColorectal Neoplasms, Hereditary Nonpolyposis/complicationsColorectal Neoplasms, Hereditary Nonpolyposis/geneticsDNA Mismatch RepairFemaleHumansLiver Neoplasms/drug therapyLiver Neoplasms/geneticsMiddle AgedNeoplasms, Multiple Primary/drug therapyNeoplasms, Multiple Primary/genetics
Substances： See more » Antibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunologicalpembrolizumab
Year: 2018 PMID： 30264147 DOI： 10.7326/L18-0360
Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391